Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Sayre

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1993
Development of fluorinated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs with potent nigrostriatal toxicity for potential use in positron emission tomography studiesS I Harik, N J Riachi, M A Hritz, et al.
Journal of Medicinal Chemistry|September 1, 1983
Importance of C-6 chirality in conferring irreversible opioid antagonism to naltrexone-derived affinity labelsL M Sayre, D L Larson, D S Fries, et al.
Chemical Research in Toxicology|October 1, 1996
Immunochemical evidence supporting 2-pentylpyrrole formation on proteins exposed to 4-hydroxy-2-nonenalL M Sayre, W Sha, G Xu, et al.
Chemical Research in Toxicology|July 18, 2000
HNE-derived 2-pentylpyrroles are generated during oxidation of LDL, are more prevalent in blood plasma from patients with renal disease or atherosclerosis, and are present in atherosclerotic plaquesR G Salomon, K Kaur, E Podrez, et al.
Alzheimer Disease and Associated Disorders|June 13, 2000
Oxidative stress, antioxidants, and Alzheimer diseaseC A Rottkamp, A Nunomura, A K Raina, et al.
Journal of Neurochemistry|January 5, 2000
In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metalsL M Sayre, G Perry, P L Harris, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 1, 1995
Haemoprotein-mediated metabolism of enamines and the possible involvement of one-electron oxidationsL M Sayre, D A Engelhart, D V Nadkarni, et al.
Archives of Biochemistry and Biophysics|August 1, 1990
Inhibition of mitochondrial respiration by analogues of the dopaminergic neurotoxin 1-methyl-4-phenylpyridinium: structural requirements for accumulation-dependent enhanced inhibitory potency on intact mitochondriaL M Sayre, M P Singh, P K Arora, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1987
On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: the effect of perinigral infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, its metabolite and their analogs in the ratS I Harik, J W Schmidley, L A Iacofano, et al.
Journal of Neurochemistry|May 1, 1997
4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's diseaseL M Sayre, D A Zelasko, P L Harris, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1993
Development of fluorinated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs with potent nigrostriatal toxicity for potential use in positron emission tomography studiesS I Harik, N J Riachi, M A Hritz, et al.
Journal of Medicinal Chemistry|September 1, 1983
Importance of C-6 chirality in conferring irreversible opioid antagonism to naltrexone-derived affinity labelsL M Sayre, D L Larson, D S Fries, et al.
Chemical Research in Toxicology|October 1, 1996
Immunochemical evidence supporting 2-pentylpyrrole formation on proteins exposed to 4-hydroxy-2-nonenalL M Sayre, W Sha, G Xu, et al.
Chemical Research in Toxicology|July 18, 2000
HNE-derived 2-pentylpyrroles are generated during oxidation of LDL, are more prevalent in blood plasma from patients with renal disease or atherosclerosis, and are present in atherosclerotic plaquesR G Salomon, K Kaur, E Podrez, et al.
Alzheimer Disease and Associated Disorders|June 13, 2000
Oxidative stress, antioxidants, and Alzheimer diseaseC A Rottkamp, A Nunomura, A K Raina, et al.
Journal of Neurochemistry|January 5, 2000
In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metalsL M Sayre, G Perry, P L Harris, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 1, 1995
Haemoprotein-mediated metabolism of enamines and the possible involvement of one-electron oxidationsL M Sayre, D A Engelhart, D V Nadkarni, et al.
Archives of Biochemistry and Biophysics|August 1, 1990
Inhibition of mitochondrial respiration by analogues of the dopaminergic neurotoxin 1-methyl-4-phenylpyridinium: structural requirements for accumulation-dependent enhanced inhibitory potency on intact mitochondriaL M Sayre, M P Singh, P K Arora, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1987
On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: the effect of perinigral infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, its metabolite and their analogs in the ratS I Harik, J W Schmidley, L A Iacofano, et al.
Journal of Neurochemistry|May 1, 1997
4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's diseaseL M Sayre, D A Zelasko, P L Harris, et al.
Pageof 8